Hatem Soliman
Impact in
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
Papers in
- Oncology 71
- Cancer Immunotherapy and Biomarkers 29
- Cancer Treatment and Pharmacology 15
- HER2/EGFR in Cancer Research 14
-
- Brain Metastases and Treatment 22
- Advanced Breast Cancer Therapies 22
- Co-authors
- Scott Antonia (20 shared papers)Farah Khalil (4 shared papers)Melanie Mediavilla-Varela (3 shared papers)Hyo S. Han (44 shared papers)Alycia Gardner (2 shared papers)Álvaro de Mingo Pulido (2 shared papers)Brian Ruffell (2 shared papers)Samuel Agresta (1 shared paper)
- Journals
- Journal of Clinical Oncology (40 papers)Cancer Research (18 papers)Breast Cancer Research and Treatment (7 papers)Journal of Neuro-Oncology (5 papers)The Oncologist (3 papers)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
Hatem Soliman
131 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 104
- Biological Psychiatry 390
- Oncology 1.6k
- Immunology 1.1k
- Cancer Research 476
- Behavioral Neuroscience 113
Countries citing papers authored by Hatem Soliman
This map shows the geographic impact of Hatem Soliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatem Soliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatem Soliman more than expected).
Fields of papers citing papers by Hatem Soliman
This network shows the impact of papers produced by Hatem Soliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatem Soliman. The network helps show where Hatem Soliman may publish in the future.
Co-authors
The 25 scholars most cited alongside Hatem Soliman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 297 | |
| 2 | 2014 | 195 | |
| 3 | 2021 | 191 | |
| 4 | 2010 | 160 | |
| 5 | 2014 | 151 | |
| 6 | 2016 | 122 | |
| 7 | 2010 | 102 | |
| 8 | 2017 | 95 | |
| 9 | 2017 | 94 | |
| 10 | 2008 | 89 | |
| 11 | 2013 | 86 | |
| 12 | 2013 | 76 | |
| 13 | 2011 | 72 | |
| 14 | 2013 | 70 | |
| 15 | 2017 | 61 | |
| 16 | 2019 | 61 | |
| 17 | 2021 | 58 | |
| 18 | 2008 | 57 | |
| 19 | 2023 | 56 | |
| 20 | 2020 | 56 |
About Hatem Soliman
Hatem Soliman is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Biological Psychiatry and Genetics, having authored 139 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (29 papers), Brain Metastases and Treatment (22 papers), Advanced Breast Cancer Therapies (22 papers), Tryptophan and brain disorders (16 papers), Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (15 papers), HER2/EGFR in Cancer Research (14 papers) and Cancer Genomics and Diagnostics (11 papers). The work is most often cited by research in Biological Psychiatry (390 citations), Oncology (1.6k citations), Immunology (1.1k citations), Cancer Research (476 citations) and Behavioral Neuroscience (113 citations). Hatem Soliman has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Scott Antonia, Farah Khalil, Melanie Mediavilla-Varela, Hyo S. Han, Alycia Gardner, Álvaro de Mingo Pulido, Brian Ruffell, Samuel Agresta, Hope S. Rugo and Lisa M. Coussens. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Breast Cancer Research and Treatment, Journal of Neuro-Oncology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.